4.1 Review

A comprehensive review on clinical outcome of probiotic and synbiotic therapy for inflammatory bowel diseases

Journal

ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
Volume 8, Issue 3, Pages 179-186

Publisher

WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/2221-1691.228000

Keywords

-

Funding

  1. CMU Post-Doctoral Fellowship, Chiang Mai University, Chiang Mai, Thailand [6592(11)/01501]

Ask authors/readers for more resources

The composition of gut microflora and its metabolic activity are closely correlated with the host immune system, and the changes in the biometric of the microbiome lead to inflammatory diseases like inflammatory bowel disease. The supplementation of probiotics and synbiotic could indeed manipulate the microflora, which can be an alternative therapy for ulcerative colitis, and Crohn's disease. Several in vitro, in vivo and clinical studies for the initiation and maintenance of remission in patients with inflammatory bowel disease have been completed. Those studies evaluated the efficacy of many probiotic formulations, especially about VSL#3. Even though the clinical studies proved that almost all the probiotic interventions are safe and bring improvement to patients, some studies are deficient in sample size, proper controls, and follow-ups. This paper summarizes the possible mechanism of inflammatory bowel disease development, probiotics, the clinical outcome of probiotic and synbiotic interventions for ulcerative colitis and Crohn's disease, as well as the adverse effect of probiotic treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available